One underlying mechanism is that increased IFN-γ secreted by tumor-specific T cells can correspondingly upregulate the expression of PD-L1 on tumor cells and APCs, which is set initially to prevent over-amplification of the immune reactions occurring in the body (130). The gene discussed is CD274; the disease is neoplasm.